Price
$3.65
Increased by 0.00%
Dollar volume (20D)
153.55 K
ADR%
7.18
Earnings report date
Nov 11, 2024
Shares float
4.71 M
Shares short
8.51 K [0.18%]
Shares outstanding
7.83 M
Market cap
28.59 M
Beta
0.56
Price/earnings
N/A
20D range
3.34 4.28
50D range
3.34 4.28
200D range
3.34 5.59

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

The company operates through two segments, Scours and Mastitis.

It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus.

The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation.

In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

It sells its products through animal health distributors.

ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 14, 24 -0.06
Increased by +81.17%
-
Feb 27, 24 -0.15
Increased by +54.03%
-
Nov 14, 23 -0.12
Decreased by -41.84%
-
Aug 10, 23 0.18
Increased by +300.00%
-
May 11, 23 -0.30
Decreased by -433.33%
-
Feb 21, 23 -0.32
Decreased by -3.10 K%
-
Nov 22, 22 -0.08
Decreased by -523.00%
-
Aug 11, 22 -0.09
Decreased by -550.00%
-
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 24 5.47 M
Increased by +54.92%
-1.53 M
Decreased by -11.01%
Decreased by -27.99%
Increased by +28.34%
Mar 31, 24 7.26 M
Increased by +110.58%
-437.87 K
Increased by +81.09%
Decreased by -6.03%
Increased by +91.02%
Dec 31, 23 5.10 M
Increased by +30.30%
-1.14 M
Increased by +31.66%
Decreased by -22.37%
Increased by +47.55%
Sep 30, 23 5.40 M
Increased by +12.52%
-940.00 K
Decreased by -43.51%
Decreased by -17.42%
Decreased by -27.54%
Jun 30, 23 3.53 M
Decreased by -8.51%
-1.38 M
Decreased by -101.67%
Decreased by -39.06%
Decreased by -120.43%
Mar 31, 23 3.45 M
Decreased by -42.55%
-2.32 M
Decreased by -414.69%
Decreased by -67.17%
Decreased by -647.81%
Dec 31, 22 3.91 M
Decreased by -28.16%
-1.67 M
Decreased by -2.34 K%
Decreased by -42.65%
Decreased by -3.22 K%
Sep 30, 22 4.80 M
Decreased by -6.88%
-655.00 K
Decreased by -543.27%
Decreased by -13.66%
Decreased by -576.01%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY